119 related articles for article (PubMed ID: 7083460)
1. Phase II trial of VP16-213 in non-small cell lung cancer (NSCLC).
Chapman R; Itri L; Gralla R; Kelsen D; Casper E; Golbey R
Cancer Chemother Pharmacol; 1982; 7(2-3):205-7. PubMed ID: 7083460
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of VP-16-213 in non-small-cell lung cancer.
Itri LM; Gralla RJ; Chapman RA; Kelsen DP; Casper ES; Golbey RB
Am J Clin Oncol; 1982 Feb; 5(1):45-7. PubMed ID: 7081137
[TBL] [Abstract][Full Text] [Related]
3. [A phase II study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung].
Konno K; Nagahama F; Nakai Y; Nakabayashi T; Hiraga Y; Takebe K; Tamura M; Oizumi K; Sato M; Ito T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):931-7. PubMed ID: 3008671
[TBL] [Abstract][Full Text] [Related]
4. [A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
Kado M; Oshima S; Matsui Y; Shimokata K; Hara K; Kanda T; Shima K; Takenaka S
Gan To Kagaku Ryoho; 1986 Jan; 13(1):116-21. PubMed ID: 3002282
[TBL] [Abstract][Full Text] [Related]
5. [A phase II study of oral VP-16 in primary lung cancer].
Matsui Y; Ohshima S; Kado M; Nakayama M; Shimokata K; Sakai S; Ito F; Chikata E; Hara K; Kanda T
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1801-7. PubMed ID: 2994576
[TBL] [Abstract][Full Text] [Related]
6. Multicenter Phase II trial of etoposide in refractory small cell lung cancer.
Issell BF; Einhorn LH; Comis RL; Lawson RD; Baker LH; Harvey HA; Lanzotti VA; Wampler GL; Daniels JR; Anderson PN
Cancer Treat Rep; 1985 Jan; 69(1):127-8. PubMed ID: 2981617
[No Abstract] [Full Text] [Related]
7. Phase II trial of daily oral etoposide in patients with advanced non-small cell lung cancer.
Saxman S; Loehrer PJ; Logie K; Stephens D; Workman F; Scullin D; Einhorn LH; Ansari R
Invest New Drugs; 1991 Aug; 9(3):253-6. PubMed ID: 1664423
[TBL] [Abstract][Full Text] [Related]
8. [A phase II study of NK171 (etoposide)].
Kimura K; Niitani H
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2011-7. PubMed ID: 2996442
[TBL] [Abstract][Full Text] [Related]
9. [Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group].
Suzuki K
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2772-9. PubMed ID: 3753024
[TBL] [Abstract][Full Text] [Related]
10. Treatment of small cell lung cancer with a combination of VP16-213 and cyclophosphamide with cisplatin or radiotherapy.
Cortés Funes H; Dominguez P; Torrubia AP; Lanzos E; Mendez M; Mendiola C
Cancer Chemother Pharmacol; 1982; 7(2-3):181-6. PubMed ID: 6282481
[TBL] [Abstract][Full Text] [Related]
11. MACC (methotrexate, doxorubicin, cyclophosphamide and lomustine) versus cis-platinum and etoposide in the treatment of advanced non-small cell lung cancer.
Buccheri G; Ferrigno D; Curcio A; Vola F; Mattalia E
Chemioterapia; 1986 Feb; 5(1):53-7. PubMed ID: 3955784
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of etoposide, vincristine, and high-dose cisplatin in advanced non-small cell lung cancer.
Bertrand M; Multhauf P; Presant C; Rappaport D; Blayney DW; Carr BI; Cecchi G; Doroshow JH; Emont E; Goldberg D
Cancer Treat Rep; 1985 Nov; 69(11):1335-6. PubMed ID: 4092199
[No Abstract] [Full Text] [Related]
13. Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trial.
Waits TM; Johnson DH; Hainsworth JD; Hande KR; Thomas M; Greco FA
J Clin Oncol; 1992 Feb; 10(2):292-6. PubMed ID: 1310104
[TBL] [Abstract][Full Text] [Related]
14. Etoposide and cisplatin salvage chemotherapy for small cell lung cancer.
Lopez JA; Mann J; Grapski RT; Nassif E; Vannicola P; Krikorian JG; Finkel H
Cancer Treat Rep; 1985 Apr; 69(4):369-71. PubMed ID: 2986833
[TBL] [Abstract][Full Text] [Related]
15. [Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)].
Gan No Rinsho; 1985 Jul; 31(8):944-52. PubMed ID: 4040986
[TBL] [Abstract][Full Text] [Related]
16. A phase I trial of continuous infusion VP16-213 (etoposide).
Aisner J; Van Echo DA; Whitacre M; Wiernik PH
Cancer Chemother Pharmacol; 1982; 7(2-3):157-60. PubMed ID: 7083457
[TBL] [Abstract][Full Text] [Related]
17. [A phase II study of etoposide (NK 171) in small cell lung cancer--comparison of results between intravenous administration and oral administration].
Furuse K
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2352-7. PubMed ID: 3000299
[TBL] [Abstract][Full Text] [Related]
18. VP16-213 combined with cis-platinum (CDDP) in the treatment of small cell carcinoma of the lung (SCLC).
Madrigal PA; Manga GP; Palomero I; Gomez RG
Cancer Chemother Pharmacol; 1982; 7(2-3):203-4. PubMed ID: 6282485
[No Abstract] [Full Text] [Related]
19. VP16-213 and cyclophosphamide in non oat cell bronchogenic carcinoma.
Morasca L; Marsoni S; Pisoni MB; Piazza E; Vago G; Casali W; Cogo R; Bianchi C; Scapaticci R
Cancer Chemother Pharmacol; 1982; 7(2-3):209-10. PubMed ID: 7083461
[TBL] [Abstract][Full Text] [Related]
20. Treatment of small cell anaplastic carcinoma of the lung with the oral solution of VP-16-213 (NSC 141540, 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside).
Hansen M; Hirsch F; Dombernowsky P; Hansen HH
Cancer; 1977 Aug; 40(2):633-7. PubMed ID: 196736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
